Global Radiopharmaceutical Administration Device Market Strategic Research Report

Scope of the Report

The global Radiopharmaceutical Administration Device market size is predicted to grow from US$ 6.65 million in 2025 to US$ 17.01 million in 2032; it is expected to grow at a CAGR of 13.7% from 2026 to 2032.

In 2025, global sales of Radiopharmaceutical Administration Device reached approximately 20–35 units, with an average market price of about USD 150000–350000 unit, an annual production capacity of roughly 25–40 units, and an industry-average gross margin of approximately 25%.

A Radiopharmaceutical Administration Device is a shielded automated system designed for the aseptic handling, transfer, inoculation, dispensing and traceable preparation of radiopharmaceutical liquids in production, quality control, sterility testing and nuclear medicine workflows. The system typically integrates lead or tungsten shielding, vial or lead-pot opening mechanisms, precision liquid transfer modules, closed or disposable fluid paths, culture-bottle handling, sealing functions, activity-measurement interfaces, batch-record software and GMP-oriented process controls. It is mainly used for PET, SPECT and therapeutic radionuclide products where operators must manage short half-life materials, radioactive exposure, sterile conditions and dose accuracy within a highly controlled workflow. The core function of the device is to replace manual manipulation of radioactive drug samples with a safer, more standardized and traceable automated process, thereby reducing operator radiation exposure, improving aseptic reliability and supporting consistent radiopharmaceutical dispensing, inoculation and sterility-test sample preparation.

Global key Radiopharmaceutical Administration Device players cover Zhejiang Tailin Bioengineering Co., Ltd., Trasis SA, Comecer S.p.A., Tema Sinergie S.p.A., Bayer AG, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Radiopharmaceutical Administration Device market?

What factors are driving Radiopharmaceutical Administration Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Radiopharmaceutical Administration Device market opportunities vary by end market size?

How does Radiopharmaceutical Administration Device break out by Type, by Application?

This report presents a comprehensive overview of the global Radiopharmaceutical Administration Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fully Automated
• Semi-automated

Segment by Format

• Vial-based System
• Syringe-based System
• Culture-bottle System

Segment by Application

• Medical
• R&D
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Radiopharmaceutical Administration Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medical, R&D, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact